Table 1 Differences in CML, CEL and MG-H1 uptake between men and women.
From: Sex-specific differences of advanced glycation end products in diabetes
Women | Men | ||
---|---|---|---|
Reference | Mean ± SD | Mean ± SD | |
CML (mg/day) | USDA | 2.61 ± 0.73 | 3.31 ± 0.98 |
Lombardo et al. *(p = 0.019) | 2.77 ± 0.97 | 4.35 ± 1.04 | |
Barrea et al. | 2.75 ± 0.76 | 3.78 ± 0.95 | |
Feraco et al. | 3.40 ± 0.89 | 4.27 ± 1.21 | |
Gil et al. | 2.57 ± 0.79 | 3.33 ± 1.14 | |
Hilger et al. | 3.16 ± 0.89 | 4.04 ± 1.14 | |
CEL (mg/day) | USDA | 1.65 ± 0.39 | 2.08 ± 0.35 |
Lombardo et al. ***(p < 0.0001) | 1.87 ± 0.51 | 3.53 ± 1.34 | |
Barrea et al. | 1.73 ± 0.52 | 2.43 ± 0.36 | |
Feraco et al. *(p = 0.014) | 1.83 ± 0.38 | 2.83 ± 0.73 | |
Gil et al. *(p = 0.030) | 1.56 ± 0.37 | 2.47 ± 0.56 | |
Hilger et al. *(p = 0.033) | 1.79 ± 0.39 | 2.69 ± 0.38 | |
MG-H1 (mg/day) | USDA | 20.51 ± 4.35 | 26.86 ± 6.00 |
Lombardo et al. | 26.88 ± 4.22 | 24.08 ± 5.08 | |
Barrea et al. | 24.22 ± 5.25 | 24.26 ± 3.88 | |
Feraco et al. | 24.28 ± 2.91 | 24.57 ± 4.01 | |
Gil et al. | 21.75 ± 4.45 | 22.88 ± 4.12 | |
Hilger et al. | 22.81 ± 4.86 | 25.29 ± 4.73 |